HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

11-deoxy-15-keto-13,14-dihydro-11 beta,16-cycloprostaglandin E2

degradation product of 15-keto-13,14-dihydro-PGE2; structure in first source
Also Known As:
11-deoxy-13,14-dihydro-15-keto-11 beta,16 xi-cyclo-PGE2; 11-deoxy-15-keto-13,14-dihydro-11 beta, 16-cyclo-PGE2; DKDBCYPGE2; PGE2-M; PGEM-II; bicyclo-PGEM; 5-Heptenoic acid, 7-(4-butyloctahydro-2,5-dioxo-1H-inden-1-yl)-
Networked: 6 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Hypercalcemia (Milk Alkali Syndrome)
3. Pelvic Pain
4. Hypotension (Low Blood Pressure)
5. Hypertension (High Blood Pressure)

Related Drugs and Biologics

1. Dinoprostone (PGE2)
2. Calcium
3. Indomethacin (Indometacin)
4. Hydrocortisone (Cortisol)
5. Hormones
6. Ceruloplasmin (Ferroxidase)
7. Captopril (Capoten)
8. 15-keto-13,14-dihydroprostaglandin F2alpha (PGFM)